The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis
特异性 NLRP3 拮抗剂 IFM-514 可减少实验性小鼠非酒精性脂肪性肝炎中的纤维化和炎症
期刊:Frontiers in Molecular Biosciences
影响因子:3.9
doi:10.3389/fmolb.2021.715765
Sandra Torres, Maximilian J Brol, Fernando Magdaleno, Robert Schierwagen, Frank E Uschner, Sabine Klein, Cristina Ortiz, Olaf Tyc, Nadine Bachtler, James Stunden, Damien Bertheloot, Ana Kitanovic, Brian Sanchez, Jacob Schrum, William R Roush, Luigi Franchi, Kate Byth, Eicke Latz, Jonel Trebicka
代谢
免疫
肝炎
IF
IHC-P
IP
WB
Human
CASP1
